跳至主要内容
临床试验/ISRCTN12205188
ISRCTN12205188已完成未知

Prospective randomised controlled trial to investigate the effectiveness of inhalers for the relief of breathlessness in patients with lung cancer and chronic obstructive pulmonary disease (COPD)

The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 72 人开始时间: 2011年2月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female, age > 35 years
  • 2. Diagnosis of non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) or mesothelioma
  • 3. Diagnosis of COPD
  • 4. Subjective dyspnoea of visual analogue score (VAS) = 4

排除标准

  • 1. Involvement in any other studies of breathlessness
  • 2. Reversible causes of breathlessness
  • 3. Patients receiving radiotherapy, chemotherapy, biological therapy or surgery. Or a plan to commence these treatments within 4 weeks
  • 4. Current use of bronchodilators either inhaled or oral (aminophyline, methyxanthines) except for short-acting bronchodilators
  • 5. Recent change to oral corticosteroid therapy dose (within 1 week of randomisation)
  • 6. Current use of beta-blockers for any reason
  • 7. Current use of anti-cholinergic containing drugs
  • 8. Current use of potent CYP30 inhibitors (ritonavir, ketoconazole, itraconazole)
  • 9. Patients with the following conditions:
  • 9.1. Asthma
  • 9.2. Severe cardiovascular disorders (myocardial infarction within 6 week)
  • 9.3. Heart rhythm abnormalities
  • 9.4. Thyrotoxicosis
  • 9.5. Uncorrected hypokalaemia
  • 9.6. Glaucoma
  • 9.7. Prostate problems
  • 9.8. Patients with difficulty passing urine
  • 9.9. Renal failure
  • 9.10. TB (current or previous)
  • 10. Pregnancy
  • 11. Patients with hypersensitivity to any of the study drugs, lactose allergy

研究者

发起方
The Royal Marsden NHS Foundation Trust (UK)

相似试验